Form 4: IGM Biosciences CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Misbah Tahir, CFO of IGM Biosciences, sold 1,570 shares of common stock on June 14, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On June 14, 2024, Misbah Tahir, the Chief Financial Officer of IGM Biosciences, sold 1,570 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $7.5753, with individual transactions occurring between $7.26 and $7.94.
- Following the transaction, Tahir directly owns 88,848 shares of IGM Biosciences common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of stock sale transaction. |
| 06/18/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.